Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 11/20 | 0.48 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.46 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.43 |
| ▸ | PRKCI | P41743 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9784058 | 0.82 | CYP19A1 (0.51) | TBXAS1CYP19A1 | |
| SCHEMBL9784048 | 0.82 | CYP19A1 (0.42) | TBXAS1CYP19A1PRKCIALDH1A1CYP1A2 | |
| SCHEMBL3237346 | 0.81 | CYP2B6 (0.56) | TBXAS1EGLN3CYP2B6CYP19A1FDPS | |
| SCHEMBL28659209 | 0.79 | TBXAS1 (0.50) | TBXAS1EGLN3CYP2B6CYP19A1PRKCI | |
| Hydrochloric Acid SCHEMBL410402 | 0.79 | CYP2B6 (0.55) | TBXAS1EGLN3CYP2B6CYP19A1FDPS | |
| SCHEMBL13350294 | 0.75 | TBXAS1 (0.54) | TBXAS1EGLN3CYP2B6CYP19A1FDPS | |
| SCHEMBL16608340 | 0.74 | CYP2B6 (0.58) | TBXAS1EGLN3CYP2B6CYP19A1FDPS | |
| SCHEMBL4773938 | 0.72 | TBXAS1 (0.75) | TBXAS1EGLN3CYP19A1PRKCIFDPS | |
| SCHEMBL16492262 | 0.71 | TBXAS1 (0.54) | TBXAS1EGLN3CYP2B6CYP19A1PRKCI | |
| SCHEMBL11051486 | 0.70 | CYP2B6 (0.68) | TBXAS1EGLN3CYP2B6CYP19A1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0676409-B1 | Erythromycin derivatives, their process for preparation and their application as medicaments | AVENTIS PHARMA SA (FR) | 2003-03-19 | — | — | EP | disclosed |
| US-5760233-A | CHEMICAL INTERMEDIATES FOR MAKING ERYTHROMYCINS ANTIBIOTICS | ROUSSEL UCLAF (FR) | 1998-06-02 | — | — | US | disclosed |
| US-5656607-A | Erythromycin derivatives | ROUSSEL UCLAF (FR) | 1997-08-12 | — | — | US | disclosed |
| WO-1995027720-A1 | NOVEL ERYTHROMYCIN DERIVATIVES, METHOD FOR PREPARING SAME AND USE THEREOF AS DRUGS | ROUSSEL UCLAF (FR) | 1995-10-19 | — | — | WO | disclosed |
| EP-0676409-A1 | Erythromycin derivatives, their process for preparation and their application as medicaments | ROUSSEL UCLAF (FR) | 1995-10-11 | — | — | EP | disclosed |